ReviewCureus2020
Use of Sodium-Glucose Co-Transporter-2 Inhibitors in Type 1 Diabetics: Are the Benefits Worth the Risks?
Tehreem Fatima et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ReviewCureus2020
Tehreem Fatima et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.